- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
July 6th, 2005
NutraLease says two human clinical trials suppport the enhanced bioavailability of CoQ10 delivered into beverages using its novel technology.
The findings will interest manufacturers of CoQ10 products, facing very high prices for the ingredient. Increasing its bioavailability, or the body's absorption of the ingredient, allows supplement and food makers to use lower dosages, therefore saving on costs.
|Related News Press|
Abalonyx launches Reduced Graphene Oxide Product: Abalonyx has successfully scaled up production of thermally reduced graphene oxide (rGO) in its Tofte, Norway, production facility. This product is now offered to customers in Kg-quantities May 10th, 2016
New Generation of Graphene Reinforced Carbon Fibre Prepreg Products March 14th, 2016
New Generation of Graphene Reinforced Carbon Fibre Prepreg Products March 10th, 2016
Designing ultrasound tools with Lego-like proteins August 29th, 2016
The NanoWizardŽ AFM from JPK is applied for interdisciplinary research at the University of South Australia for applications including smart wound healing and how plants can protect themselves from toxins July 26th, 2016